Fast deep learning reconstruction techniques for preclinical magnetic resonance fingerprinting.

Journal: NMR in biomedicine
Published Date:

Abstract

We propose a deep learning (DL) model and a hyperparameter optimization strategy to reconstruct T and T maps acquired with the magnetic resonance fingerprinting (MRF) methodology. We applied two different MRF sequence routines to acquire images of ex vivo rat brain phantoms using a 7-T preclinical scanner. Subsequently, the DL model was trained using experimental data, completely excluding the use of any theoretical MRI signal simulator. The best combination of the DL parameters was implemented by an automatic hyperparameter optimization strategy, whose key aspect is to include all the parameters to the fit, allowing the simultaneous optimization of the neural network architecture, the structure of the DL model, and the supervised learning algorithm. By comparing the reconstruction performances of the DL technique with those achieved from the traditional dictionary-based method on an independent dataset, the DL approach was shown to reduce the mean percentage relative error by a factor of 3 for T and by a factor of 2 for T , and to improve the computational time by at least a factor of 37. Furthermore, the proposed DL method enables maintaining comparable reconstruction performance, even with a lower number of MRF images and a reduced k-space sampling percentage, with respect to the dictionary-based method. Our results suggest that the proposed DL methodology may offer an improvement in reconstruction accuracy, as well as speeding up MRF for preclinical, and in prospective clinical, investigations.

Authors

  • Raffaella Fiamma Cabini
    INFN, Pavia division, Pavia, Italy.
  • Leonardo Barzaghi
    Department of Mathematics, University of Pavia, Pavia, Italy.
  • Davide Cicolari
    Department of Physics, University of Pavia, Pavia, Italy.
  • Paolo Arosio
    Department of Chemistry and Applied Biosciences, Institute for Chemical and Bioengineering, Swiss Federal Institute of Technology, Zurich 8093, Switzerland. Electronic address: paolo.arosio@chem.ethz.ch.
  • Stefano Carrazza
    Department of Physics, University of Milan, Milan, Italy.
  • Silvia Figini
    INFN, Pavia division, Pavia, Italy.
  • Marta Filibian
    INFN, Istituto Nazionale di Fisica Nucleare, Pavia, Italy.
  • Andrea Gazzano
    Laboratory of Cellular and Molecular Neuropharmacology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia, Italy.
  • Rolf Krause
    Euler Institute, USI, Lugano, Switzerland.
  • Manuel Mariani
    Department of Physics, University of Pavia, Pavia, Italy.
  • Marco Peviani
    Laboratory of Cellular and Molecular Neuropharmacology, Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Pavia, Italy.
  • Anna Pichiecchio
    Advanced Imaging and Radiomics Center, Neuroradiology Department, IRCCS Mondino Foundation, Pavia, Italy.
  • Diego Ulisse Pizzagalli
    Euler Institute, USI, Lugano, Switzerland.
  • Alessandro Lascialfari
    INFN, Pavia division, Pavia, Italy.